top of page
Pioneering live biotherapeutics
in the respiratory tract.
Use tab to navigate through the menu items.
Pulmobiotics announces award of 1.9m € EIC Transition funding
Safety and Efficacy results of engineered PB_VAP strain published today in Nature Biotechnology.
Novel genome editing tool published in Nucleic Acid Research by Pulmobiotics SL
First manuscript of Pulmobiotics:
Premio Nacional de Biologia
Pulmobiotics obtained the price from the Catalan Society of Biology to the Start-up 2021
Dr. Carlos Piñero Lambea and Dr. Rocco Mazzolini obtain the Torres Quevedo Contract
Lluch has been selected to be part of the training programme for female entrepreneurs called Academ
Pulmobiotics SL secures two million euro investment
bottom of page